ProQR Therapeutics (PRQR) Short Interest Ratio & Short Volume $1.56 -0.03 (-1.89%) As of 12:18 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ProQR Therapeutics Short Interest DataProQR Therapeutics (PRQR) has a short interest of 376,000 shares, representing 0.50% of the float (the number of shares available for trading by the public). This marks a -54.45% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 618,485 shares to cover all short positions.Current Short Interest376,000 sharesPrevious Short Interest825,500 sharesChange Vs. Previous Month-54.45%Dollar Volume Sold Short$624,160.00Short Interest Ratio0.7 Days to CoverLast Record DateApril 30, 2025Outstanding Shares105,213,000 sharesShort Percent of Float0.50%Today's Trading Volume195,243 sharesAverage Trading Volume618,485 sharesToday's Volume Vs. Average32% Short Selling ProQR Therapeutics? Sign up to receive the latest short interest report for ProQR Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPRQR Short Interest Over TimePRQR Days to Cover Over TimePRQR Percentage of Float Shorted Over Time ProQR Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025376,000 shares $624,160.00 -54.5%0.5%0.7 $1.66 4/15/2025825,500 shares $982,345.00 -2.1%1.1%1.6 $1.19 3/31/2025843,100 shares $1.12 million -17.3%1.1%1.8 $1.33 3/15/20251,020,000 shares $1.72 million +12.7%1.4%2.4 $1.69 2/28/2025904,800 shares $2.11 million -6.3%1.2%2.1 $2.33 2/15/2025965,900 shares $2.34 million +4.4%1.3%2.4 $2.42 1/31/2025925,500 shares $1.96 million -8.4%N/A1.9 $2.12 1/15/20251,010,000 shares $2.31 million +10.0%N/A1.7 $2.29 12/31/2024918,100 shares $2.43 million +151.7%N/A0.6 $2.65 12/15/2024364,700 shares $1.03 million +94.4%N/A0.2 $2.83 Get the Latest News and Ratings for PRQR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProQR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/2024187,600 shares $720,384.00 -54.7%N/A0.1 $3.84 11/15/2024413,800 shares $1.58 million -38.9%N/A0.3 $3.82 10/31/2024677,600 shares $2.37 million +408.3%N/A0.5 $3.50 10/15/2024133,300 shares $241,273.00 -10.5%0.3%0.1 $1.81 9/30/2024148,900 shares $270,998.00 -6.2%0.3%1.1 $1.82 9/15/2024158,700 shares $293,595.00 -4.3%0.3%1.5 $1.85 8/31/2024165,900 shares $335,118.00 -4.5%0.3%1.5 $2.02 8/15/2024173,700 shares $387,351.00 +6.9%0.3%1.5 $2.23 7/31/2024162,500 shares $313,625.00 -5.4%0.3%1.7 $1.93 7/15/2024171,700 shares $300,475.00 -0.9%0.3%1.7 $1.75 6/30/2024173,200 shares $287,512.00 -11.9%0.3%1.5 $1.66 6/15/2024196,600 shares $346,016.00 -18.5%0.4%1.6 $1.76 5/31/2024241,200 shares $470,340.00 +3.7%0.5%1.7 $1.95 5/15/2024232,500 shares $444,075.00 +8.0%0.5%1.5 $1.91 4/30/2024215,300 shares $417,682.00 -10.9%0.4%1.1 $1.94 4/15/2024241,500 shares $493,867.50 -7.5%0.5%1.2 $2.05 3/31/2024261,100 shares $597,892.89 -4.0%0.5%0.9 $2.29 3/15/2024272,100 shares $696,576.00 +3.1%0.5%0.9 $2.56 2/29/2024263,900 shares $533,078.00 -17.3%0.6%0.9 $2.02 2/15/2024319,000 shares $622,050.00 +5.9%0.7%1 $1.95 1/31/2024301,300 shares $653,821.00 -39.1%0.6%0.9 $2.17 1/15/2024494,800 shares $1.10 million -27.3%1.0%1.6 $2.23 12/31/2023680,400 shares $1.35 million -30.7%1.4%3.3 $1.98 12/15/2023981,100 shares $2.11 million +55.8%2.0%4.3 $2.15 11/30/2023629,800 shares $976,190.00 +2.6%1.3%2.9 $1.55 11/15/2023613,600 shares $908,128.00 -9.0%1.2%3.5 $1.48 10/31/2023674,200 shares $775,330.00 -4.5%1.4%3.8 $1.15 10/15/2023705,800 shares $868,134.00 +2.9%1.4%3.7 $1.23 9/30/2023685,900 shares $891,670.00 -24.4%1.4%3.3 $1.30 9/15/2023907,500 shares $1.46 million -3.6%1.8%4.7 $1.61Your $300 account credit is about to expire (Ad)Update to MarketBeat All Access and Save $300 on Your Annual SubscriptionStart Your Risk-Free Trial Here 8/31/2023940,900 shares $1.51 million -2.9%1.7%3.9 $1.61 8/15/2023969,400 shares $1.49 million -16.4%1.8%3.5 $1.54 7/31/20231,160,000 shares $1.74 million +148.1%2.1%3.6 $1.50 7/15/2023467,600 shares $818,300.00 -2.9%0.9%1.3 $1.75 6/30/2023481,300 shares $779,706.00 -8.4%0.9%1.2 $1.62 6/15/2023525,200 shares $892,840.00 -34.0%0.9%0.8 $1.70 5/31/2023796,200 shares $1.39 million -41.9%1.4%1 $1.74 5/15/20231,370,000 shares $2.63 million -33.5%2.5%1.6 $1.92 4/30/20232,060,000 shares $4.49 million -20.2%3.7%2.3 $2.18 4/15/20232,580,000 shares $5.75 million -4.1%4.6%2.6 $2.23 3/31/20232,690,000 shares $5.73 million +66.1%5.1%2.2 $2.13 3/15/20231,620,000 shares $5.02 million +21.8%3.5%0.6 $3.10 2/28/20231,330,000 shares $3.92 million +16.7%2.9%0.5 $2.95 2/15/20231,140,000 shares $3.28 million -23.0%2.5%0.4 $2.88 1/31/20231,480,000 shares $4.08 million -20.0%3.1%0.5 $2.76 1/15/20231,850,000 shares $6.35 million -7.5%3.9%0.6 $3.43 12/30/20222,000,000 shares $7.40 million +102.0%4.2%0.8 $3.70 12/15/2022990,200 shares $1.64 million +0.1%1.7%0.4 $1.66 11/30/2022989,600 shares $1.22 million +44.3%1.7%1.3 $1.23 11/15/2022685,700 shares $654,980.64 -34.7%1.2%1 $0.96 10/31/20221,050,000 shares $971,355.00 -16.0%1.8%1.9 $0.93 10/15/20221,250,000 shares $1.11 million +131.4%2.2%2.6 $0.89 9/30/2022540,300 shares $401,983.20 +54.6%0.9%1.2 $0.74 9/15/2022349,600 shares $276,114.08 +1.7%0.6%0.9 $0.79 8/31/2022343,900 shares $271,646.61 +6.7%0.6%0.8 $0.79 8/15/2022322,300 shares $286,847.00 +3.2%0.6%0.7 $0.89 7/31/2022312,300 shares $261,582.48 -7.1%0.6%0.6 $0.84 7/15/2022336,000 shares $268,800.00 -52.0%0.6%0.5 $0.80 6/30/2022699,900 shares $544,522.20 +33.5%1.2%0.8 $0.78 6/15/2022524,400 shares $399,120.84 -27.4%1.0%0.5 $0.76 5/31/2022722,500 shares $476,850.00 -29.9%1.3%0.7 $0.66 5/15/20221,030,000 shares $638,600.00 -10.4%1.9%0.9 $0.62 4/30/20221,150,000 shares $796,950.00 -28.1%2.1%0.6 $0.69 4/15/20221,600,000 shares $1.26 million +27.0%2.9%0.8 $0.79 3/31/20221,260,000 shares $1.14 million -8.7%2.3%0.7 $0.91 3/15/20221,380,000 shares $1.28 million -31.7%2.5%0.8 $0.93 2/28/20222,020,000 shares $2.16 million -37.5%3.7%1.3 $1.07 2/15/20223,230,000 shares $4.07 million +46.2%5.9%2.2 $1.26 1/31/20222,210,000 shares $12.04 million +82.6%3.9%4.7 $5.45 1/15/20221,210,000 shares $8.18 million +45.2%2.5%3.2 $6.76 12/31/2021833,400 shares $6.68 million +23.7%1.7%2.5 $8.01 12/15/2021673,600 shares $4.75 million +6.4%1.4%1.6 $7.05 11/30/2021633,300 shares $4.47 million -35.5%1.3%0.9 $7.06 11/15/2021981,200 shares $7.61 million -41.9%2.0%1.4 $7.76 10/29/20211,690,000 shares $13.05 million -13.3%3.4%2.4 $7.72 10/15/20211,950,000 shares $15.37 million +8.3%3.9%2.6 $7.88 9/30/20211,800,000 shares $15.07 million -2.7%3.6%2.4 $8.37 9/15/20211,850,000 shares $15.30 million -12.3%3.7%2.7 $8.27 8/31/20212,110,000 shares $14.09 million -9.8%4.0%3.1 $6.68 8/13/20212,340,000 shares $14.72 million +29.3%4.4%4.8 $6.29Your $300 account credit is about to expire (Ad)Update to MarketBeat All Access and Save $300 on Your Annual SubscriptionStart Your Risk-Free Trial Here 7/30/20211,810,000 shares $9.47 million -0.6%3.2%3.6 $5.23 7/15/20211,820,000 shares $10.06 million -4.2%3.4%3.5 $5.53 6/30/20211,900,000 shares $12.81 million +14.5%3.5%3 $6.74 6/15/20211,660,000 shares $12.32 million -15.3%3.1%0.5 $7.42 5/28/20211,960,000 shares $12.23 million -23.7%3.6%0.6 $6.24 5/14/20212,570,000 shares $16.19 million +62.7%N/A0.8 $6.30 4/30/20211,580,000 shares $10.13 million -23.3%N/A0.5 $6.41 4/15/20212,060,000 shares $13.02 million -21.1%N/A0.6 $6.32 3/31/20212,610,000 shares $18.61 million +125.0%N/A0.7 $7.13 3/15/20211,160,000 shares $5.75 million +29.0%N/A1.6 $4.96 2/26/2021899,400 shares $4.09 million -1.3%N/A1.3 $4.55 2/12/2021910,900 shares $4.58 million +4.6%N/A1.4 $5.03 1/29/2021870,800 shares $4.20 million -21.6%N/A1.4 $4.82 1/15/20211,110,000 shares $4.98 million +84.2%N/A2.1 $4.49 12/31/2020602,500 shares $2.51 million -39.1%N/A1.9 $4.17 12/15/2020988,700 shares $4.25 million -16.2%N/A3.3 $4.30 11/30/20201,180,000 shares $4.85 million +45.8%N/A4.7 $4.11 11/15/2020809,200 shares $3.29 million +14.9%N/A3.5 $4.07 10/30/2020704,200 shares $2.69 million +3.7%N/A4.2 $3.82 10/15/2020678,900 shares $3.10 million +2.7%N/A4.1 $4.56 9/30/2020661,100 shares $3.17 million -2.2%N/A4.6 $4.79 9/15/2020676,000 shares $3.56 million -1.7%N/A4.6 $5.27 8/31/2020687,800 shares $4.33 million +0.1%N/A4.5 $6.30 8/14/2020687,000 shares $3.62 million +1.5%N/A4.6 $5.27 7/31/2020676,600 shares $3.50 million +4.6%N/A4.5 $5.17 7/15/2020646,900 shares $3.18 million +2.9%N/A4.2 $4.92 6/30/2020628,500 shares $3.82 million +58.3%N/A4.2 $6.08 6/15/2020397,100 shares $2.08 million +4.2%N/A2.2 $5.25 5/29/2020381,200 shares $2.12 million -21.6%N/A2 $5.56 5/15/2020486,000 shares $2.50 million -9.9%N/A2.4 $5.14 PRQR Short Interest - Frequently Asked Questions What is ProQR Therapeutics' current short interest? Short interest is the volume of ProQR Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 376,000 shares of PRQR short. 0.50% of ProQR Therapeutics' shares are currently sold short. Learn More on ProQR Therapeutics' current short interest. What is a good short interest ratio for ProQR Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PRQR shares currently have a short interest ratio of 1.0. Learn More on ProQR Therapeutics's short interest ratio. Which institutional investors are shorting ProQR Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ProQR Therapeutics: Simplex Trading LLC, Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for ProQR Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.50% of ProQR Therapeutics' floating shares are currently sold short. Is ProQR Therapeutics' short interest increasing or decreasing? ProQR Therapeutics saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 376,000 shares, a drop of 54.5% from the previous total of 825,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ProQR Therapeutics' short interest compare to its competitors? 0.50% of ProQR Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ProQR Therapeutics: Immunome, Inc. (17.76%), Cronos Group Inc. (2.09%), Xeris Biopharma Holdings, Inc. (13.39%), ArriVent BioPharma, Inc. (27.56%), Dianthus Therapeutics, Inc. (27.85%), Trevi Therapeutics, Inc. (10.17%), Organogenesis Holdings Inc. (18.28%), Arbutus Biopharma Co. (6.15%), AbCellera Biologics Inc. (10.27%), KalVista Pharmaceuticals, Inc. (13.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Strategy Incorporated ($10.45 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), Apollo Global Management, Inc. ($3.83 billion), The Kroger Co. ($2.56 billion), Hims & Hers Health, Inc. ($2.06 billion), Dell Technologies Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.90 billion), Amcor plc ($1.76 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short ProQR Therapeutics stock? Short selling PRQR is an investing strategy that aims to generate trading profit from ProQR Therapeutics as its price is falling. PRQR shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ProQR Therapeutics? A short squeeze for ProQR Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PRQR, which in turn drives the price of the stock up even further. How often is ProQR Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRQR, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies IMNM Short Interest CRON Short Interest XERS Short Interest AVBP Short Interest DNTH Short Interest TRVI Short Interest ORGO Short Interest ABUS Short Interest ABCL Short Interest KALV Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PRQR) was last updated on 5/13/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProQR Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share ProQR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PRQR Stock Free PRQR Stock Alerts